Immunoglobulin expression in non-lymphoid lineage and neoplastic cells

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1139-1148

  Chen, Zhengshan ^a   Qiu, Xiaoyan ^a   Gu, Jiang ^a,b,c,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANTOU UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d Chinese Pathology of Association   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD79A ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; RAG1 PROTEIN; RAG2 PROTEIN;

ARTICLE; B LYMPHOCYTE; BRAIN ISCHEMIA; BREAST ADENOCARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; COLON ADENOCARCINOMA; EPITHELIUM CELL; GENE ACTIVATION; GENE FUNCTION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; LIVER CARCINOMA; LUNG CARCINOMA; MOLECULAR DYNAMICS; NASOPHARYNX CANCER; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STROKE; TONGUE CANCER; TUMOR CELL LINE; UTERINE CERVIX CANCER; VDJ EXON; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; NEOPLASM; REVIEW;

ANIMALS; CELL LINEAGE; EPITHELIAL CELLS; HUMANS; IMMUNOGLOBULINS; NEOPLASMS; NEURONS;

EID: 65349144223     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080879     Document Type: Review

References (103)

1. Davies DR, Padlan EA, Segal DM: Three-dimensional structure of immunoglobulins. Annu Rev Biochem 1975, 44:639-667
2. Amzel LM, Poljak RJ: Three-dimensional structure of immunoglobulins. Annu Rev Biochem 1979, 48:961-997
3. Reth M: Antigen receptors on B lymphocytes. Annu Rev Immunol 1992, 10:97-121
4. Kurosaki T: Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol 1999, 17:555-592
5. Daeron M: Fc receptor biology. Annu Rev Immunol 1997, 15:203-234
6. van de Winkel JG, Anderson CL: Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991, 49:511-524
7. Unkeless JC, Scigliano E, Freedman VH: Structure and function of human and murine receptors for IgG. Annu Rev Immunol 1988, 6:251-281
8. Raghavan M, Bjorkman PJ: Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol 1996, 12:181-220
9. Davies DR, Metzger H: Structural basis of antibody function. Annu Rev Immunol 1983, 1:87-117
10. Ravetch JV, Clynes RA: Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998, 16:421-432
11. Honjo T: Immunoglobulin genes. Annu Rev Immunol 1983, 1:499-528
12. Malcolm S, Barton P, Murphy C, Ferguson-Smith MA, Bentley DL, Rabbitts TH: Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. Proc Natl Acad Sci USA 1982, 79:4957-4961
13. Erikson J, Martinis J, Croce CM: Assignment of the genes for human lambda immunoglobulin chains to chromosome 22. Nature 1981, 294:173-175
14. McBride OW, Hieter PA, Hollis GF, Swan D, Otey MC, Leder P: Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes. J Exp Med 1982, 155:1480-1490
15. Kirsch IR, Morton CC, Nakahara K, Leder P: Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science 1982, 216:301-303
16. McBride OW, Battey J, Hollis GF, Swan DC, Siebenlist U, Leder P: Localization of human variable and constant region immunoglobulin heavy chain genes on subtelomeric band q32 of chromosome 14. Nucleic Acids Res 1982, 10:8155-8170
17. Early P, Huang H, Davis M, Calame K, Hood L: An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D, and JH. Cell 1980, 19:981-992
18. Jung D, Giallourakis C, Mostoslavsky R, Alt FW: Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006, 24:541-570
19. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877
20. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Abt FW: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867
21. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA: Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell1995, 83:387-395
22. van Gent DC, McBlane JF, Ramsden DA, Sadofsky MJ, Hesse JE, Gellert M: Initiation of V(D)J recombination in a cell-free system. Cell 1995, 81:925-934
23. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG: The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 2000, 18:495-527
24. Eastman QM, Leu TM, Schatz DG: Initiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature 1996, 380:85-88
25. Sawchuk DJ, Weis-Garcia F, Malik S, Besmer E, Bustin M, Nussenzweig MC, Cortes P: V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA- bending proteins. J Exp Med 1997, 185:2025-2032
26. Rooney S, Chaudhuri J, Alt FW: The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev 2004, 200:115-131
27. Jacob J, Kelsoe G, Rajewsky K, Weiss U: Intraclonal generation of antibody mutants in germinal centres. Nature 1991, 354:389-392
28. Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, Banchereau J, Mills FC, Max EE, Martinez-Valdez H: Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996, 4:241-250
29. Honjo T, Kinoshita K, Muramatsu M: Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002, 20:165-196
30. Wagner SD, Neuberger MS: Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996, 14:441-457
31. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T: Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999, 274:18470-18476
32. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A: Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575
33. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563
34. Petersen S, Casellas R, Reina-San-Martin B, Chen HT, Difilippantonio MJ, Wilson PC, Hanitsch L, Celeste A, Muramatsu M, Pilch DR, Redon C, Ried T, Bonner WM, Honjo T, Nussenzweig MC, Nussenzweig A: AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001, 414:660-665
35. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T: The AID enzyme induces class switch recombination in fibroblasts. Nature 2002, 416:340-345
36. Petersen-Mahrt SK, Harris RS, Neuberger MS: AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103
37. Yoshikawa K, Okazaki IM, Eto T, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T: AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 2002, 296:2033-2036
38. Kimoto Y: Expression of heavy-chain constant region of immuno- globulin and T-cell receptor gene transcripts in human non-hema- topoietic tumor cell lines. Genes Chromosomes Cancer 1998, 22:83-86
39. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001, 61:2129-2137
40. Li J, Tan C, Xiang Q, Zhang X, Ma J, Wang JR, Yang J, Li W, Shen SR, Liang S, Li G: Proteomic detection of changes in protein synthesis induced by NGX6 transfected in human nasopharyngeal carcinoma cells. J Protein Chem 2001, 20:265-271
41. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P, Li G, Lv P, Li Z, Sun X, Wu L, Zheng J, Deng Y, Hou C, Tang P, Zhang S, Zhang Y: Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 2003, 63:6488-6495
42. Zheng S, Cao J, Geng L: [Structure and expression of colorectal cancer related Immunoglobulin novel gene SNC73]. Zhonghua Yi Xue Za Zhi 2001, 81:485-488
43. Hu J, Deng Y, Zheng S: [Expression of a novel immunoglobulin gene SNC73 in human cancer and its significance]. Zhonghua Zhong Liu Za Zhi 2002, 24:38-40
44. Geng LY, Zheng S, Peng JP: [Expression and recombination mechanism of SNC73 (IgHalpha1) in human epithelial cancer cell line]. Zhonghua Yi Xue Za Zhi 2003, 83:1493-1496
45. Hu JB, Zheng S, Deng YC: Expression of a novel immunoglobulin gene SNC73 in human cancer and non-cancerous tissues. World J Gastroenterol 2003, 9:1054-1057
46. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS: Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 2006, 66:3996-4000
47. Chen Z, Gu J: Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 2007, 21:2931-2938
48. Zheng H, Li M, Ren W, Zeng L, Liu HD, Hu D, Deng X, Tang M, Shi Y, Gong J, Cao Y: Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol 2007, 44:2221-2227
49. Zhu X, Li C, Sun X, Mao Y, Li G, Liu X, Zhang Y, Qiu X: Immunoglobulin mRNA and protein expression in human oral epithelial tumor cells. Appl Immunohistochem Mol Morphol 2008, 16:232-238
50. Liu HD, Zheng H, Li M, Hu DS, Tang M, Cao Y: Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF- kappaB and AP-1 pathways. Cell Signal 2007, 19:419-427
51. Li M, Feng DY, Ren W, Zheng L, Zheng H, Tang M, Cao Y: Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol 2004, 36:2250-2257
52. Geng LY, Shi ZZ, Dong Q, Cai XH, Zhang YM, Cao W, Peng JP, Fang YM, Zheng L, Zheng S: Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. World J Gastroenterol 2007, 13:2305-2311
53. Yang S, Wang M, You W: [Co-expression of immunoglobulin light chain kappa and lambda in gastric carcinoma cell]. Zhonghua Zhong Liu Za Zhi 2002, 24:465-466
54. Hesslein DG, Pflugh DL, Chowdhury D, Bothwell AL, Sen R, Schatz DG: Pax5 is required for recombination of transcribed, acetylated, 5'IgH V gene segments. Genes Dev 2003, 17:37-42
55. Yancopoulos GD, Alt FW: Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 1985, 40:271-281
56. Bolland DJ, Wood AL, Johnston CM, Bunting SF, Morgan G, Chakalova L, Fraser PJ, Corcoran AE: Antisense intergenic transcription in V(D)J recombination. Nat Immunol 2004, 5:630-637
57. Schlissel MS, Baltimore D: Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 1989, 58:1001-1007
58. Schlissel M, Voronova A, Baltimore D: Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev 1991, 5:1367-1376
59. Dudley DD, Chaudhuri J, Bassing CH, Alt FW: Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol 2005, 86:43-112
60. Singh H, Medina KL, Pongubala JM: Contingent gene regulatory networks and B cell fate specification, Proc Natl Acad Sci USA2005,102:4949-4953
61. Medina KL, Singh H: Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol 2005, 12:203-209
62. Medina KL, Singh H: Gene regulatory networks orchestrating B cell fate specification, commitment, and differentiation. Curr Top Micro- biol Immunol 2005, 290:1-14
63. Busslinger M: Transcriptional control of early B cell development. Annu Rev Immunol 2004, 22:55-79
64. Hagman J, Lukin K: Transcription factors drive B cell development. Curr Opin Immunol 2006, 18:127-134
65. Ye M, Graf T: Early decisions in lymphoid development. Curr Opin Immunol 2007, 19:123-128
66. Fuxa M, Skok JA: Transcriptional regulation in early B cell development. Curr Opin Immunol 2007, 19:129-136
67. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 1994, 79:875-884
68. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, Van der Valk M, de Riele H, Berns A, Munroe C: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994, 79:885-892
69. Lin H, Grosschedl R: Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995, 376:263-267
70. Romanow WJ, Langerak AW, Goebel P, Wolvers-Tettero IL, van Dongen JJ, Feeney AJ, Murre C: E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell 2000, 5:343-353
71. Goebel P, Janney N, Valenzuela JR, Romanow WJ, Murre C, Feeney AJ: Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med 2001, 194:645-656
72. Fuller K, Storb U: Identification and characterization of the murine Rag1 promoter. Mol Immunol 1997, 34:939-954
73. Lauring J, Schlissel MS: Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines. Mol Cell Biol 1999, 19:2601-2612
74. Wei XC, Kishi H, Jin ZX, Zhao WP, Kondo S, Matsuda T, Saito S, Muraguchi A: Characterization of chromatin structure and enhancer elements for murine recombination activating gene-2. J Immunol 2002, 169:873-881
75. Hsu LY, Lauring J, Liang HE, Greenbaum S, Cado D, Zhuang Y, Schlissel MS: A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 2003, 19:105-117
76. Wei XC, Dohkan J, Kishi H, Wu CX, Kondo S, Muraguchi A: Characterization of the proximal enhancer element and transcriptional regulatory factors for murine recombination activating gene-2. Eur J Immunol 2005, 35:612-621
77. Choi JK, Shen CP, Radomska HS, Eckhardt LA, Kadesch T: E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J 1996, 15:5014-5021
78. Reynaud D, Demarco IA, Reddy KL, Schjerven H, Bertolino E, Chen Z, Smale ST, Winandy S, Singh H: Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol 2008, 9:927-936
79. Kishi H, Wei XC, Jin ZX, Fujishiro Y, Nagata T, Matsuda T, Mura- guchi A: Lineage-specific regulation of the murine RAG-2 promoter: gATA-3 in T cells and Pax-5 in B cells. Blood 2000, 95:3845-3852
80. Inlay MA, Tian H, Lin T, Xu Y: Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. J Exp Med 2004, 200:1205-1211
81. Fuxa M, Skok J, Souabni A, Salvagiotto G, Roldan E, Busslinger M: Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev 2004, 18:411-422
82. Liao W, Tang M, Li JJ, Leo ML, Cao Y: Epstein-Barr virus encoded latent membrane protein 1 increases expression of immunoglobulin kappa light chain through NFkappaB in a nasopharyngeal carcinoma cell line. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) [Chinese Journal of Biochemistry and Biophysics] 1999, 31:659-663
83. Deng YQ, Zheng J, Li GH, Zhu XH, Zhang P, Huang J, Zhang YM, Li ZX, Qiu XY: [Immunoglobulin expression in colon cancer cell line HT-29 and its biological activities]. Zhonghua Zhong Liu Za Zhi 2006, 28:88-91
84. Zheng H, Li M, Liu H, Ren W, Hu DS, Shi Y, Tang M, Cao Y: Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int 2007, 31:82-87
85. Schreiber H, Wu TH, Nachman J, Rowley DA: Immunological enhancement of primary tumor development and its prevention. Semin Cancer Biol 2000, 10:351-357
86. Prehn RT: Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Cancer Res 1994, 54:908-914
87. Prehn RT: The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in kera- toacanthoma. Cancer Res 1996, 56:937-940
88. Snell GD: Incompatibility reactions to tumor homotransplants with particular reference to the role of the tumor; a review. Cancer Res 1957, 17:2-10
89. Kaliss N: Immunological enhancement of tumor homografts in mice: a review. Cancer Res 1958, 18:992-1003
90. Manson LA: Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement. Clin Immunol Immunopathol 1994, 72:1-8
91. Hellstrom I, Hellstrom KE, Evans CA, Heppner GH, Pierce GE, Yang JP: Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci USA 1969, 62:362-368
92. Sjogren HO, Hellstrom I, Bansal SC, Hellstrom KE: Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci USA 1971, 68:1372-1375
93. Huang J, Sun X, Mao Y, Zhu X, Zhang P, Zhang L, Du J, Qiu X: Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons. Int J Biochem Cell Biol 2008, 40:1604-1615
94. Naegele JR, Barnstable CJ, Wahle PR: Expression of a unique 56-kDa polypeptide by neurons in the subplate zone of the developing cerebral cortex. Proc Natl Acad Sci USA 1991, 88:330-334
95. Henschel R, Wahle P: The SP1 antigen in subplate neurons of the developing cat cortex is an immunoglobulin-like molecule. Eur J Neurosci 1994, 6:1239-1246
96. Dunn JA, Kirsch JD, Naegele JR: Transient immunoglobulin-like molecules are present in the subplate zone and cerebral cortex during postnatal development. Cereb Cortex 1995, 5:494-505
97. Upender MB, Dunn JA, Wilson SM, Naegele JR: Immunoglobulin molecules are present in early-generated neuronal populations in the rat cerebral cortex and retina. J Comp Neurol 1997, 384: 271-282
98. Yoshimi K, Woo M, Son Y, Baudry M, Thompson RF: IgG-immuno- staining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG. Brain Res 2002, 956:53-66
99. Kazatchkine MD, Kaveri SV: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001, 345:747-755
100. Hartung HP: Advances in the understanding of the mechanism of action of IVIg. J Neurol 2008, 255 Suppl 3:3-6
101. Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J: Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 2008, 29:608-615
102. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, Magnus T, Chan SL, Jo DG, Ouyang X, Fairlie DP, Granger DN, Vortmeyer A, Basta M, Mattson MP: Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci USA 2007, 104:14104-14109
103. Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM: Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 2009, 158:1074-1089